GOLGA8B
Summary:
| Name | OMIM ID | Ensembl ID | HGNC ID | PHARMGKB ID | Map Location |
|---|---|---|---|---|---|
| golgin A8 family member B | MIM:609619 | Ensembl:ENSG00000215252 | HGNC:HGNC:31973 | PA142671717 | 15q14 |
GO terms in GOLGA8B
| Term Type | Evidence Type | GO Term ID | GO Des. |
|---|---|---|---|
| CC | IBA | GO:0000137 | Golgi cis cisterna |
| CC | IBA | GO:0005794 | Golgi apparatus |
| CC | IDA | GO:0005794 | Golgi apparatus |
| CC | IBA | GO:0005801 | cis-Golgi network |
| CC | IDA | GO:0005829 | cytosol |
| CC | IBA | GO:0032580 | Golgi cisterna membrane |
| CC | IEA | GO:0032580 | Golgi cisterna membrane |
| BP | IBA | GO:0007030 | Golgi organization |
| BP | IBA | GO:0051225 | spindle assembly |
| BP | IBA | GO:0051225 | spindle assembly |
Gene expression in normal tissue: GOLGA8B
Gene-model tissue-cancer distribution: Bubble Plot
Gene-drug pathway distribution
Pathways in GOLGA8B
| Database | Pathway ID | Pathway Des. |
|---|
Gene-Drug: Aster Plot
| Drug ID | Drug Name | Model Num. |
|---|---|---|
| iGMDRD123 | Isoevodiamine | 3 |
| iGMDRD177 | Teniposide | 1 |
| iGMDRD280 | CYTOCHALASIN B | 3 |
| iGMDRD61 | Kinetin riboside | 1 |
| iGMDRD57 | Chloropentafluorobenzene | 3 |
| iGMDRD316 | N9-Isopropyl-olomoucine | 3 |
| iGMDRD446 | LY 2183240 | 3 |
| iGMDRD405 | PIK-75 | 3 |
| iGMDRD144 | NSC95397 | 4 |
| iGMDRD486 | Tosedostat | 1 |
| iGMDRD126 | Tipifarnib | 5 |
| iGMDRD322 | FK 866 | 3 |
| iGMDRD640 | CAY10618 | 3 |
| iGMDRD300 | Tozasertib | 1 |
| iGMDRD398 | Sepantronium | 5 |
| iGMDRD366 | PI-103 | 1 |
| iGMDRD329 | Merck60 | 2 |
| iGMDRD506 | Fedratinib | 2 |
| iGMDRD188 | Piperlongumine | 1 |
| iGMDRD100 | Zebularine | 2 |
| iGMDRD414 | MST-312 | 3 |
| iGMDRD871 | BRD6368 | 2 |
| iGMDRD187 | BRD9876 | 1 |
| iGMDRD481 | Dactolisib | 1 |
| iGMDRD434 | BMS-536924 | 4 |
| iGMDRD137 | Indisulam | 3 |
| iGMDRD513 | BML-259 | 2 |
Gene in drug-gene network: Network Plot

Gene-drug targets distribution
Gene Structure: PDB
Models in GOLGA8B

